Correction to article on growth in 'branded generics'
Todd Chermak is Abbott's head of innovation and development for emerging markets. "Drug Makers Find 'Branded Generics' Are a Source for Growth" at 8:10 ET, incorrectly spelled his surname as Chermark in the 24th paragraph. (Oct. 23)
(END) Dow Jones Newswires
October 23, 2017 11:11 ET (15:11 GMT)